Expert Interview

This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

Discussing the standard of care and potential of Hoth Therapeutics BioLexa, a topical formulation being developed for treatment of atopic dermatitis

Ticker(s): HOTH

Who's the expert?

Institution: Omni Dermatology

Practices general, cosmetic, and surgical dermatology, including MOHS surgery.
treats 5 - 20 patients per week for psoriasis
Excited about Bimzelx and familiar with P3 results

Interview Goal

The focus of this interview will be on Hoth Therapeutics recent announcement of positive final results from their 14 day the the Phase 1b clinical trial of BioLexa as a therapeutic for atopic dermatitis

Do you want answers to these questions?

Yes! Sign me up for FREE
so I can learn more Yes.
LOGIN!

Click Here to Access
This Project

Slingshot Insights Explained

JOIN FOR FREE TODAY

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

Click Here to Access
This Project

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.